Skip to content
Clinicians
Member Value Tools
Practice Insights
Verana Trial Connect
Quality Measures Dashboards
MIPS Advisory Offerings
Manual Data Entry
Verana Research Network
Evolve Registry
Life Sciences
Clinical Development
HEOR & Medical Affairs
Commercialization
Research
Partners
Societies
CROs
Technology and Data
Company
About
Team
Press
Blog
Careers
Privacy
Patient Privacy
Privacy Policy
Products
Ophthalmology Qdata
Anti-VEGF Market Tracker
Diabetic Retinopathy
Dry Eye Disease
Cataracts
Geographic Atrophy
Glaucoma
Neovascular AMD
Retinitis Pigmentosa
Thyroid Eye Disease
Uveitic Macular Edema
Qdata Explorer
Other Ophthalmic Conditions
Oncology Qdata
Neurology Qdata
Multiple Sclerosis
Parkinson’s Disease
Spinal Muscular Atrophy
Other Neurological Conditions
Urology Qdata
Benign Prostatic Hyperplasia
Bladder Cancer
Prostate Cancer
Other Urological Conditions
Clinical Trials
Site Explorer
Solutions
Clinical Research
Trial Design
Protocol Optimization & Site Selection
Patient Recruitment
Prospective Evidence Generation (PEG)
Market Insights
Market Tracking
Brand Switching
Prescriber Mapping
RWE Studies
Patient Segmentation
Safety Studies
Natural History of Disease / Disease Progression
Comparative Effectiveness
Treatment Patterns & Outcomes
Healthcare Resource Utilization (HCRU) Cost
Phase IV Studies / Surveillance
Contact Us
Clinicians
Member Value Tools
Practice Insights
Verana Trial Connect
Quality Measures Dashboards
MIPS Advisory Offerings
Manual Data Entry
Verana Research Network
Evolve Registry
Life Sciences
Clinical Development
HEOR & Medical Affairs
Commercialization
Research
Partners
Societies
CROs
Technology and Data
Company
About
Team
Press
Blog
Careers
Privacy
Patient Privacy
Privacy Policy
Products
Ophthalmology Qdata
Anti-VEGF Market Tracker
Diabetic Retinopathy
Dry Eye Disease
Cataracts
Geographic Atrophy
Glaucoma
Neovascular AMD
Retinitis Pigmentosa
Thyroid Eye Disease
Uveitic Macular Edema
Qdata Explorer
Other Ophthalmic Conditions
Oncology Qdata
Neurology Qdata
Multiple Sclerosis
Parkinson’s Disease
Spinal Muscular Atrophy
Other Neurological Conditions
Urology Qdata
Benign Prostatic Hyperplasia
Bladder Cancer
Prostate Cancer
Other Urological Conditions
Clinical Trials
Site Explorer
Solutions
Clinical Research
Trial Design
Protocol Optimization & Site Selection
Patient Recruitment
Prospective Evidence Generation (PEG)
Market Insights
Market Tracking
Brand Switching
Prescriber Mapping
RWE Studies
Patient Segmentation
Safety Studies
Natural History of Disease / Disease Progression
Comparative Effectiveness
Treatment Patterns & Outcomes
Healthcare Resource Utilization (HCRU) Cost
Phase IV Studies / Surveillance
Contact Us
Press
Verana Health Enhances MIPS Advisory Services to Help Medical Practices to Maximize Program Benefits, Reduce Compliance Burden, and Improve Patient Care
October 7, 2025
Read More...
Verana Health Introduces Significant Data and Software Enhancements to Support Ophthalmologic Research and Treatment Optimization
October 2, 2025
Read More...
Verana Health Launches Qdata® Cataracts, the Largest Dataset of Its Kind for Cataract Research
April 23, 2025
Read More...
Verana Health Enhances Site Explorer Tool to Advance Diversity in Clinical Trials
March 4, 2025
Read More...
Verana Health and Nanoscope Therapeutics Announce Collaboration to Accelerate Retinitis Pigmentosa Research
February 25, 2025
Read More...
Verana Health Debuts Qdata Explorer in Advance of American Academy of Ophthalmology 2024 Annual Meeting
October 9, 2024
Read More...
Verana Health Introduces Qdata Explorer in Advance of 2024 American Academy of Ophthalmology Annual Meeting
October 8, 2024
Read More...
Verana Health CEO Named PharmaVoice 100 Winner
October 8, 2024
Read More...
How The Healthcare Industry Can Use AI In Clinical Trial Recruitment
September 30, 2024
Read More...
Verana Health Announces Launch of Qdata® BPH
September 30, 2024
Read More...
« Previous
1
2
3
4
…
25
Next »